Lymphatic smooth muscle cell (LSMC)

Lymphatic smooth muscle cells (LSMCs) are specialized contractile cells located in the tunica media of collecting lymphatic vessels. They are the primary drivers of the intrinsic lymphatic pump, generating spontaneous, rhythmic phasic contractions and maintaining vessel tone to propel lymph fluid through the lymphatic network against hydrostatic and oncotic pressure gradients. This activity is essential for maintaining tissue fluid homeostasis, absorbing dietary lipids, and facilitating the transport of immune cells and antigens to lymph nodes. LSMCs exhibit a unique hybrid phenotype, sharing structural and functional characteristics with both vascular smooth muscle cells and cardiac myocytes, such as the expression of voltage-gated sodium channels (Nav1.5) and ryanodine receptors (RyR2). Dysfunction of these cells, leading to impaired contractility or vessel wall remodeling, is a central feature of primary and secondary lymphedema and is increasingly recognized as a factor in chronic inflammatory diseases like rheumatoid arthritis and obesity. While no therapies are currently approved specifically to target LSMC function, they are sensitive to various pharmacological agents, including calcium channel blockers and adrenergic agonists, which can modulate lymphatic drainage or contribute to drug-induced lymphedema.

Other names

Lymphatic muscle cellLMCLymphatic contractile cellCollecting lymphatic vessel smooth muscle cell

Inhibition of L-type and T-type voltage-gated calcium channels; Antagonism of ryanodine receptors; Activation of alpha- and beta-adrenergic receptors; Inhibition of Rho-associated protein kinase 2 (ROCK2); Modulation of myosin light chain kinase (MLCK) activity.